Introduction
Metal dyshomeostasis is known to be involved in the etiology of an umber of pathologies such as Wilson's, Alzheimer's,P arkinson's, and Niemann-Pickd iseases and cancer.N eurodegenerative disorders and cancerh ave long been viewed as among the most enigmatic and problematici ssues in biomedicine, and their multifaceted nature have been well-documented. The precise mechanisms responsible for triggering these disorders remainu nclear;h owever,t hey share multifactorial pathogenic mechanisms relatedt om etal dyshomeostasis and, as ac onsequence, oxidative stress.C onsidering the multifactorialn ature of thesed iseases, it is becoming more and more evident that the next generation of drugs must have multiple functions to combat the multiple processes of disease progression;m etal ions represent ap romisingt herapeutic target as they could be as tartingp oint to hit multiple targets. On the other hand, especiallyi nt he treatment of cancer,d rugs should ideally be directedt ot he site of action in order to decrease their side effects on healthy tissues and enhance their uptake by targeted cells.
The doctoral research described here focused on the synthesis and evaluation of multifunctional molecules that could interferew ith different key target points of neurodegeneration andc ancer.8 -Hydroxyquinoline( OHQ), am etal chelator,w as chosen as am olecular scaffold to build selective prodrugs and multifunctional metal-binding compounds because it hase merged as ap rivileged structure for new drug candidates. The synthesis, characterization and biological evaluation of new covalent glycoconjugates with OHQ derivatives (Figure 1 ) are reported in the Thesis. Glycosylation is as uccessful strategyf or improving severalf eatureso ft heses ystems-in addition to the increase in solubility, as ugar moiety typically confers selectivity and multifunctionality.
Glycoconjugated Prodrugs
New glucoconjugates and galactoconjugates of OHQ derivatives were designed in order to exploit the unique features common to cancer cells, such as the high expression of certain proteins( e.g., b-glucosidases and glucosetransporters) and the high levelsofcopper(II) ions. These features can be synergistically combinedt oo btain new compounds that are highly specific for neoplastic cells, minimizing chemotherapeutic side effects. The main advantageso ft heseg lycosylated compounds are targeting and prevention of side effects due to systemic chelation. The chelating function of these compounds is masked, and they must be subjectt oh ydrolysis through specific b-glucosidases or b-galactosidases to liberate the activea glycone in targeted cells.
The new glycoconjugates were obtained through aone-pot reaction in good yields using amodified Michael procedure. The pure products were characterized by mass spectrometry and NMR, and were then biologically evaluated.
The glucoconjugates exhibit significant antiproliferative activity,w ith the exception of 2-methyl-8-quinolinyl-b-d-glucopyranoside; the activity of the compounds was remarkably enhanced by the presence of copperi ons. Furthermore, the results obtained in the presence of a b-glucosidase inhibitor, 2,5-dideoxy-2,5-imino-d-mannitol (DMDP), unequivocally confirm the crucial role of b-glucosidase activity to allow the release of the active quinoline moiety in order to developt he antiproliferative activity (Figure 2 ). The in vitro cleavage studies suggest that the glucoconjugates are differently hydrolyzed by b-glucosidase. These data are consistentw ith the resultso ft he antiproliferativea ctivity assay and docking studies. In some cases, the antiproliferativea ctivity of the prodrugs was inferiort ot hat of their parentc ompounds indicating the incomplete cleavage of the glycosidic bond for these compounds. In particular, 2-methyl-8-quinolinyl-b-d-glucopyranoside, which is inactive, is the compound cleaved over al onger time period in comparison with the other glucosides. These experimental results are supportedb yd ockings tudies;2 -methyl-8-quinolinyl-b-d-glucopyranoside shows ad ifferent binding pose compared with the chlorinated compounds (5-chloro-8-quinolinyl-b-d-glucopyranoside and 5,7-dichloro-8-quinolinyl-b-d-glucopyranoside). More precisely,i ti sp redicted to have the highest binding affinity for the active site of b-glucosidase, suggesting that prodrugs with longerh alf-life values are more tightly boundt ot he actives ite than those with shorter half-life values. It can be deduced as al ogical consequence that the glucoconjugatest ightly bound to the enzymea re more slowly hydrolyzed. In summary,t he glucoconjugates could be actively transported into the cells (e.g.,b yg lucose transporters). The cytosolic b-glucosidase could hydrolyze the compounds that could complex copper(II) ions (present in large amountsi nc ancer tissues)and exert their antiproliferative action. Free OHQs could have multiple targets causing cancer cell death by apoptosis.
Chemical conjugation of OHQs with galactose leads to new prodrugs with ac ytotoxic differential of approximately 100-fold compared with their parent compounds. This degree of prodrug activation is an ecessary requirement in developing antibody directed enzyme prodrug therapy (ADEPT). The resultsr eported in the Thesis strongly suggest that attachment of the galactose residuetoOHQ leads to almost complete drug inactivation, and that the glycosidic bond is highlys table under the conditions used in the in vitro assay. Interestingly,2 -amino-8-quinolinyl-b-d-galactopyranoside (GalAHQ) and 5-nitro-8-quinolinyl-b-d-galactopyranoside (GalNHQ) show pharmacological relevant activity in the presence of Cu 2 + .T heir activity is cell-line-dependent,a nd they could be good candidates for targeted delivery to human ovarian carcinoma, exploiting prodrug monotherapy approach. Unlike glucoconjugates, the galactosides do not easily reach the lysosomal enzymes within the cell and thus they are not rapidly cleaved;t he exceptions were GalNHQa nd GalAHQ, which were shown to be partially hydrolyzed within 72 hi nc ell lines where there is an overexpressiono fg alactosidase. However,t he presenceo fe xogenous b-galactosidase increases the antiproliferativea ctivity of the galactoconjugates, confirming that the compounds are hydrolyzed by the enzyme and that the latter is able to exert its optimal activity at ap Hc loset o that of the tumor extracellularf luid. To conclude,t hese prodrugs have interesting properties that render them suitablef or ADEPT approach.
Chelating Glycoconjugates
Chelating 8-hydroxyquinolinec onjugates with monosaccharides, disaccharidesa nd oligosaccharides have also been synthesized in order to compare their properties to those of the glycosylatedprodrugs. Unlike the latter compounds, they are able to complex Cu 2 + and Zn 2 + ions with high stability constants.
In particular,t he new cyclodextrin-8-hydroxyquinoline conjugates (CyD-OHQ)c entero nt he belief that "one molecule-multiple targets" is an approach with remarkable advantages comparedt o" one molecule-one target" strategy.C yD-OHQs were synthetized by an amide condensation or as tepwise reductivea mination, functionalizing the cyclodextrin at the uppero rl ower rim with one or two OHQ moieties. The characterization and unequivocal structurala ssignments of the compounds were achieved by ac ombination of techniques including circulard ichroism, mass spectrometry,U V-vis and NMR spectroscopy.
CyD-OHQs have significant antioxidant capacity on the basis of in vitro antioxidant assays,s uperior to that of aw ell-known antioxidant,T rolox. The compounds can complex Cu 2 + and Zn 2 + ions with conditional stability constants in aqueous solution similaro rh igher to/than those of OHQ (Figure 3) . This behavior could be explained by the presenceo fa ne xocyclic nitrogen available to complex the metal ion.T he metal-ligand (ML) main speciesw ith the metal ion bound by the nitrogen atom of the pyridine ring, the phenolate anda mino or amide groups can be hypothesized. The exocyclic nitrogen stabilizes the ML species in comparison to OHQ. The conditional stability constant of ML 2 species is significantly lower than the one calculated for OHQa st he presence of the exocyclic nitrogen destabilized this species. Copper(II) complexes of the conjugates exhibit high superoxide dismutase (SOD)-like activity.M oreover, these ligandsa re also able to strongly inhibitm etal-inducedp rotein aggregation as demonstrated by an effective assay that exploits the formation of amyloid fibrils when b-lactoglobulinA (BLG) is heatedi nt he presence of metal ions (Figure 4) . Obviously,t hese features are highly desirable considering the critical involvement of metal ions in protein misfolding anda ggregation, which are hallmarks of several neurodegenerative disorders.
Antiproliferative studies of the compounds in the absence or presence of Cu 2 + on five different cell lines demonstrated relatively high IC 50 values. These resultss uggest that thesea gents couldb ea dministered in relativelyh igh concentrations, for use as antioxidant and antiaggregant drugs,i fn ecessary, without damage to healthy tissues. It is cleart hat the cyclodextrin moiety renders the systemsl ess toxic compared with the respective OHQ derivatives.
These compounds could have great potentiala st herapeutic agents in the treatment of neurodegenerative diseases related to oxidative stress and metal dyshomeostasis,s uch as Alzheimer's disease and especially Niemann-PickT ype C. Apart from improving the aqueous solubility due to the presence of the saccharidic residue, the hybrid systemsm ight have advantageous features including the possibility of forming inclusion complexes with coformulating drugs and/or to include endogenous compounds, such as cholesterol,i no rder to remove them from the body.M oreover,t he presence of the bulky b-cyclodextrin moiety might provide ap latform for improved pharmacokinetics of the drug conjugatesp rotecting, for example, from glucuronidation or sulfation of OHQs. 
